NEXAF Trial Shows Hybrid Exercise Cuts AFib Burden 45% Over One Year

The NEXAF study randomized 295 Norwegian patients averaging age 64 to usual care or a hybrid intervention of eight supervised high-intensity sessions followed by home-based training monitored via smartwatch and app. All received insertable cardiac monitors for continuous AFib burden tracking. The primary outcome of AFib burden fell 45% relatively in the exercise arm, accompanied by 37% fewer total hospitalizations and 46% fewer AFib-related admissions, plus gains in cardiorespiratory fitness.

This result aligns with prior observational data from the CARDIO-FIT and LEGACY cohorts linking higher fitness to lower AFib recurrence, yet NEXAF supplies the first RCT-level confirmation using objective monitoring rather than symptom reports. It addresses a key gap: many AFib patients avoid exercise fearing triggers, but the structured approach here demonstrates safety and efficacy when intensity is titrated. The hybrid delivery model also improves scalability over fully supervised programs.

Remaining questions include durability beyond 12 months, applicability to more diverse ethnic and socioeconomic groups, and whether benefits persist after the structured phase ends. A larger multicenter replication with longer follow-up is needed before guidelines can shift exercise from adjunct to primary therapy.

Next steps should prioritize publication of full results, cost-effectiveness analysis, and integration trials embedding this protocol into routine cardiology pathways.